Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993284priorityCriticalpatent/ECSP993284A/en
Publication of ECSP993284ApublicationCriticalpatent/ECSP993284A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención se refiere a la combinación del inhibidor de la 3-hidroxi-3-metil-glutaril-coenzima-A(inhibidor de la HMG-CoA), cerivastatina, con fibratos y a su uso en la profilaxis y tratamiento de trastornos y enfermedades del metabolismo de los lípidos así como de enfermedades causadas por ello.The present invention relates to the combination of the 3-hydroxy-3-methyl-glutaryl-coenzyme-A inhibitor (HMG-CoA inhibitor), cerivastatin, with fibrates and to their use in the prophylaxis and treatment of disorders and diseases. of lipid metabolism as well as diseases caused by it.
ECSP9932841999-12-171999-12-17
COMBINATION OF CERIVASTATIN AND FIBRATES REF: (LEA 33479-EC)
ECSP993284A
(en)